Is extended-spectrum beta-lactamase-producing Escherichia coli rectal carriage at hospital admission predictable? Risk factors at hospital admission

Journal of Hospital Infection

Volumn 76, Issue 2, 2010, Pages 178-180

  Schnell, D ^a   Kouatchet, A T ^b   Lecuyer H ^a   Talbi, A ^a   Descamps, P ^a   Nassif, X ^a   Zahar, J R ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; HISTAMINE H2 RECEPTOR ANTAGONIST; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AFRICA; AGE; ANTIBIOTIC THERAPY; ASIA; CHEMOTHERAPY; CHILD; CHRONIC KIDNEY FAILURE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; ESCHERICHIA COLI; FEMALE; GEOGRAPHY; GREECE; GUYANA; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; LETTER; LIVER DISEASE; MALE; MIDDLE EAST; PREVALENCE; RECTUM; RISK FACTOR; SEX; STEROID THERAPY; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; BETA-LACTAMASES; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TESTS, ROUTINE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ADMISSION; RECTUM; RISK FACTORS; YOUNG ADULT;

EID: 77956173165     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.05.019     Document Type: Letter

References (8)

1. Zahar J.R., Lortholary O., Martin C., Potel G., Plesiat P., Nordmann P. Addressing the challenge of extended-spectrum beta-lactamases. Curr Opin Invest Drugs 2009, 10:172-180.
2. Thouverez M., Talon D., Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol 2004, 25:838-841.
3. Rooney P.J., O'Leary M.C., Loughrey A.C., et al. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 2009, 64:635-641.
4. Ben-Ami R., Schwaber M.J., Navon-Venezia S., et al. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis 2006, 42:925-934.
5. Friedmann R., Raveh D., Zartzer E., et al. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009, 30:534-542.
6. Kader A.A., Kumar A., Kamath K.A. Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 2007, 28:1114-1116.
7. Laupland K.B., Church D.L., Vidakovich J., Mucenski M., Pitout J.D. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 2008, 57:441-448.
8. Tham J., Odenholt I., Walder M., Brolund A., Ahl J., Melander E. Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis 2010, 42:275-280.